Koyfin Home > Directory > Health Care > Arena Pharmaceutical > EBIT

Arena Pharmaceutical EBIT Chart (ARNA)

Arena Pharmaceutical annual/quarterly EBIT from 2000 to 2018. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Arena Pharmaceutical EBIT for the quarter ending December 12, 2018 was $-45m a 30.63% decrease of -14m year over year
  • Arena Pharmaceutical EBIT for the last 12 months ending December 12, 2018 was $-145m a 38.01% decrease of -55m year over year
  • Arena Pharmaceutical Annual EBIT for 2018 was $-145m a 44.75% decrease of -65m from 2017
  • Arena Pharmaceutical Annual EBIT for 2017 was $-80m a 101.07% decrease of -81m from 2016
  • Arena Pharmaceutical Annual EBIT for 2016 was $1m a 11,856.57% increase of 101m from 2015
Other Income Statement Metrics:
  • Arena Pharmaceutical EBITDA for the quarter ending December 12, 2018 was $-44m a 31.55% decrease of -14m year over year
  • Arena Pharmaceutical Net Income for the quarter ending December 12, 2018 was $69m a 146.52% increase of 101m year over year
  • Arena Pharmaceutical Total Revenue for the quarter ending September 09, 2018 was $4m a -330.00% decrease of -12m year over year
View Chart On Koyfin

Quarterly ARNA EBIT Data

12/2018$-45m
09/2018$-36m
06/2018$-33m
03/2018$-31m
12/2017$-14m
09/2017$-22m
06/2017$-23m
03/2017$-21m
09/2016$-10m
06/2016$-20m

Annual ARNA EBIT Data

2018$-145m
2017$-80m
2016$1m
2015$-100m
2014$-105m
2013$-23m
2012$-57m
2011$-79m
2010$-96m
2009$-135m